Geriatrics
Conference Coverage
VIDEO: HFSA Roundtable, part 2: Prevention offers best HFpEF strategy
Heart failure with preserved ejection fraction reflects premature aging of the vasculature and myocardium that is best managed by prevention.
Conference Coverage
High-risk patients fared best in lifestyle intervention trial for cognitive decline
Key clinical point: Targeting nutrition, exercise, and cardiovascular risk factors improved cognition in elderly people at risk of cognitive...
Conference Coverage
CHEST: Catheter-directed thrombolysis shows pulmonary embolism efficacy
Key clinical point: Catheter-directed thrombolysis was linked to reduced mortality, compared with systemic thrombolysis in patients with an acute...
Conference Coverage
Shorter sleep linked to faster kidney function decline
Shorter sleep duration is prospectively and independently associated with a faster decline in renal function, according to results from a large...
News
Raloxifene ineffective for treating AD patients
Treatment with raloxifene does not significantly improve cognitive function in women with Alzheimer’s disease, results of a U.S. study suggest.
Conference Coverage
VIDEO: Bioresorbable vascular scaffolds serve niche patients
Conference Coverage
Duodenoscopes often cultured high-concern organisms
Key clinical point: High-concern organisms often contaminated duodenoscopes after ERCP. Major finding: Investigators cultured these bacteria from...
Conference Coverage
Gastrointestinal and liver diseases remain substantial public health burden
Hospital admissions and associated costs for Clostridium difficile infection, inflammatory bowel disease, and liver disease all rose substantially...
Conference Coverage
High free thyroxine may increase risk of sudden cardiac death
Key clinical point: Even subclinical hyperthyroidism may increase the risk of sudden cardiac death. Major finding: High free thyroxine in...
Commentary
ADHD in the elderly: An unexpected diagnosis
Conference Coverage
CHEST: Losartan slows emphysema progression in pilot trial
Key clinical point: A year of daily treatment with losartan produced significant slowing of emphysema progression in a placebo-controlled pilot...